scholarly journals Evaluation of sexual dysfunction prevalence in infertile men with non-obstructive azoospermia

2020 ◽  
Vol 91 (4) ◽  
pp. 241-244
Author(s):  
Taha Numan Yıkılmaz ◽  
Erdem Öztürk ◽  
Nurullah Hamidi ◽  
İsmail Selvi ◽  
Halil Başar ◽  
...  
Keyword(s):  
Erectile Dysfunction ◽  
Sexual Dysfunction ◽  
Premature Ejaculation ◽  
Sexual Relationship ◽  
Sexual Disorders ◽  
Obstructive Azoospermia ◽  
Male Partners ◽  
Negative Effects ◽  
Infertile Couples ◽  
Relationship Stress

Objectives: To determine the prevalence of sexual dysfunction in male partners of infertile couples and evaluate the effect of childlessness on erectile dysfunction (ED) and sexual relationship stress. Materials and methods: We collected datas of couples who attended our clinics for infertility between 2009 and 2016. Erectile dysfunction was investigated with the Questionnaires of International Index of Erectile Function-15 (IIEF-15) whereas premature ejaculation (PE) status with the Premature Ejaculation Diagnostic Tool (PEDT). The stress status of the childlessness in terms of sexual intercourse was scored by the Visual analogue scale (VAS) questionnaire. These scores were measured before and after a successful assisted reproductive treatment with the birth of the child. Results: The median age of the 193 male patients was 31 years (range 23-48). Erectile dysfunction was found in 68 (35.2%) and PE in 42 (21.7%) subjects. One hundred and forty-one couples were treated with assisted reproductive treatments. Forty eight couples had successful pregnancy. The IIEF-15 test was repeated after the birth of the child to the male partners of these couples. We observed that the IIEF-15 scores increased from 16 to 21 (p = 0.014). However there were no significant improvement on their ejaculation status (p > 0.05). The mean VAS scores of male partners was 5.2 (3-10) in the treatment period while it decreased to 4.1 (0-8) after the birth of the chils (p = 0.02). Statistically analysis showed a correlation between VAS and infertility as did IIEF-15. Conclusions: We observed that having children has a reducing effect on sexual relationship stress. Infertility is absolutely blamed on the women and men. This condition may have negative effects on male sexual performance and it is closely related with some emerging female sexual disorders. It should be taken into consideration that infertile couples may have sexual dysfunction.

Pharmacologic Treatment Strategies for Sexual Dysfunction in Patients with Epilepsy and Depression

CNS Spectrums ◽  
2006 ◽  
Vol 11 (S9) ◽  
pp. 31-37 ◽  
Author(s):  
Glen L. Stimmel ◽  
Mary A. Gutierrez
Keyword(s):  
Erectile Dysfunction ◽  
Sexual Dysfunction ◽  
Sexual Desire ◽  
Selective Serotonin Reuptake Inhibitors ◽  
Premature Ejaculation ◽  
Sexual Disorders ◽  
Comorbid Condition ◽  
Phosphodiesterase Type 5 Inhibitor ◽  
Female Orgasmic Disorder ◽  
Patients With Epilepsy

AbstractSexual dysfunction is a frequently encountered comorbid condition in patients with many medical and psychiatric conditions, such as epilepsy and depression. Most depressed patients experience some type of sexual dysfunction, decreased sexual desire being the most common. The association of sexual dysfunction with epilepsy is less clear. Changes in sex hormone levels are common in patients with epilepsy and may be attributable to the disease or to antiepileptic drugs (AEDs). Sexual dysfunction associated with depression or epilepsy is generally treated according to standard guidelines for the management of sexual disorders, since data from special populations are not available. The most common forms of female sexual dysfunction are lack of sexual desire and difficulty achieving orgasm. There are no approved pharmacotherapies for female hypoactive sexual desire disorder or female orgasmic disorder. Female sexual arousal disorder is treated with estrogen replacement therapy when indicated or vaginal lubricants. The most common male sexual dysfunction disorders are premature ejaculation and erectile dysfunction.  Phosphodiesterase type-5 inhibitor drugs are now the first-line treatment for erectile dysfunction, and selective serotonin reuptake inhibitors and topical anesthetic creams are nonapproved but effective treatments for premature ejaculation. Testosterone and aromatase inhibitors have been used investigationally to treat sexual dysfunction in men taking AEDs. Patient education and follow-up appointments are essential to ensure optimal outcomes of pharmacologic treatments for sexual dysfunction.

scholarly journals Premature Ejaculation and Erectile Dysfunction in Male Partners of Infertile Couples: Prevalence and Correlation

2019 ◽  
Vol 01 (03) ◽  
pp. 126-130
Author(s):  
Thanh Tam Thi Ho ◽  
Minh Tam Le ◽  
Quang Vinh Truong ◽  
Vu Quoc Huy Nguyen ◽  
Ngoc Thanh Cao
Keyword(s):  
Erectile Dysfunction ◽  
Premature Ejaculation ◽  
University Hospital ◽  
Male Partners ◽  
Reciprocal Effect ◽  
Cross Sectional ◽  
Validated Questionnaires ◽  
Male Sexual Dysfunction ◽  
Infertile Couples ◽  
The Relationship

Objectives: The frequency of, and relationship between, the various manifestations of male sexual dysfunction in infertile couples have been poorly investigated, especially in Vietnam. Our study aims to assess the prevalence of premature ejaculation and erectile dysfunction in infertile couples using validated instruments, and the relationship between these disorders. Method: Cross-sectional descriptive study, using validated questionnaires including the Premature Ejaculation Diagnostic Tool (PEDT) and the International Index of Erectile Function-15 (IIEF-15), to measure the incidence of these problems in 255 male partners of infertile couples who were examined from January through December 2017, at the Center for Reproductive Endocrinology & Infertility, Hue University Hospital. Results: The prevalence of overt premature ejaculation was 4.7%, probable premature ejaculation was 7.1%, and erectile dysfunction was 26.3% (mild: 19.3%, mild-to-moderate: 3.9%, moderate: 2.7%, and severe: 0.4%). The PEDT total score was negatively correlated to IIEF-15-EFD and IIEF-15 total scores (r [Formula: see text]0.322 and r [Formula: see text]0.348, respectively). Conclusions:In light of the identified prevalence of premature ejaculation and erectile dysfunction in the studied population, screening for these conditions should be included in the evaluation of infertile couples. These two disorders could negatively reciprocal effect on each other.

scholarly journals Spermatorrhea in a Chinese patient with temporal lobe epilepsy: a case report

2021 ◽  
Vol 49 (1) ◽  
pp. 030006052098281
Author(s):  
Liang Zhang ◽  
Hao Yu ◽  
Dan Li ◽  
Hui Qian ◽  
Yuchao Chen
Keyword(s):  
Erectile Dysfunction ◽  
Case Report ◽  
Sexual Dysfunction ◽  
Temporal Lobe Epilepsy ◽  
Temporal Lobe ◽  
Neurological Disorder ◽  
Premature Ejaculation ◽  
Chinese Patient ◽  
Left Temporal Lobe ◽  
Rare Manifestation

Epilepsy is a chronic neurological disorder that is characterized by episodes of seizure. Sexual dysfunction has been reported in patients with seizure, which mostly manifests as erectile dysfunction and premature ejaculation in men. In this study, we report the case of a 65-year-old Chinese man with frequent spermatorrhea. Electroencephalography suggested local epilepsy in the left temporal lobe. After treatment with anti-epilepsy drugs, the symptoms disappeared and did not recur. To the best of our knowledge, this is the first reported case of epilepsy-induced spermatorrhea. The symptoms of spermatorrhea are probably a rare manifestation of seizure. When repetitive stereotyped symptoms occur, seizure should be considered, and tentative anti-epileptic treatment may be a good option.

scholarly journals SEXUAL DISORDERS AFTER HEART TRANSPLANT

2020 ◽  
Vol 73 (10) ◽  
pp. 2277-2281
Author(s):  
Kamila Fuczyło ◽  
Magdalena Piegza ◽  
Robert Pudlo
Keyword(s):  
Quality Of Life ◽  
Erectile Dysfunction ◽  
Sexual Dysfunction ◽  
Heart Transplantation ◽  
Heart Transplant ◽  
Sexual Disorders ◽  
State Of Health ◽  
Review Of The Literature ◽  
Pubmed Database

The aim: To systematize and bring the reader closer to knowledge about the occurrence of sexual disorders in people after heart transplantation based on available bibliography. Material and methods: A review of the literature on this topic from the last 30 years made with using the PubMed database, using a total of 17 articles. Conclusions: The incidence of sexual dysfunction (SD) is higher in heart recipients than in the general population and erectile dysfunction is the most common. When the symptoms of dysfunction occur before the transplant – they do not improve, rather they get worse, which reduces the improvement in the quality of life of these patients compared to patients without sexual dysfunction. Improvement in quality of life is observed in patients with SD after heart transplantation, but not as pronounced as in subjects without sexual dysfunction. Some patients notice an increase in libido, with the genital response being insufficient or completely disappearing, which results in a decrease in the quality of relationships between partners and a deterioration in the quality of life. The cause of SD in heart recipients is unclear, but it is associated with the type of immunosuppression used, the level of sexual activity and the state of health of patients prior to transplantation. Nowadays patients after ortotrophic heart transplant live longer and their quality of life improves, but not in sexual terms. The articles concerned almost exclusively men, that is why the topic requires exploration in subsequent research.

scholarly journals Psycho-sexual Disorders in Clinic Diabetes mellitus Patients of a Teaching Hospital of Eastern Nepal

2020 ◽  
Vol 4 (2) ◽  
pp. 19-23
Author(s):  
Dhana Ratna Shakya ◽  
R Maskey ◽  
P Karki ◽  
SK Sharma
Keyword(s):  
Diabetes Mellitus ◽  
Erectile Dysfunction ◽  
Sexual Dysfunction ◽  
Teaching Hospital ◽  
Sexual Experience ◽  
Tertiary Care ◽  
Sexual Disorders ◽  
Diabetic Patients ◽  
Diabetes Clinic ◽  
Patients With Diabetes

Background: Diabetes mellitus, a chronic disease, is frequently associated with sexual dysfunctions. Identification and management of these dysfunctions are important for overall wellbeing of the patient, though usually neglected. We lack data on this regard from Nepal. Objective: To estimate prevalence of psycho-sexual disorders (with emphasis on erectile dysfunction) in the patients with diabetes mellitus visiting ‘Diabetes clinic’ of a tertiary care teaching hospital in eastern Nepal. Method: It is a hospital-clinic based prevalence study. This study analyzed consecutive diabetes mellitus clinic patients’ response to self response questionnaires ‘Arizona Sexual Experience Scale’ (ASEX) for over all sexual dysfunction and ‘5- Item Version of the International Index of Erectile Dysfunction’ (IIEF-5) for erectile dysfunction. ‘Diabetes mellitus’ diagnosis was made based on the ADA guidelines 2010. Results: Among 100 male clinic diabetes patients, majorities were married, above age 50 years and all diagnosed as type 2 diabetes mellitus. Out of total, 48% had sexual dysfunction by the ASEX and many subjects had erectile dysfunction by the IIEF-5. Conclusion: Psychosexual dysfunctions, mainly erectile dysfunction are common among diabetic patients. Hence, assessment should include attention to sexual problems as well during management of diabetes mellitus.

scholarly journals Use of neuro-psychiatry medicines in patients with sexual dysfunction: a retrospective study

2017 ◽  
Vol 6 (3) ◽  
pp. 563 ◽  
Author(s):  
Amit Shrenikraj Mutha ◽  
Vijay Rajaram Kulkarni ◽  
Amit Suresh Beldar ◽  
Sadiq Bapumiya Patel
Keyword(s):  
Erectile Dysfunction ◽  
Retrospective Study ◽  
Sexual Dysfunction ◽  
Psychiatric Disorders ◽  
Medical Records ◽  
Psychiatric Comorbidity ◽  
Neuropsychiatric Disorders ◽  
Sexual Problems ◽  
Sexual Disorders ◽  
Time Of Presentation

Background: The objective of the study was to understand the usage of neuro-psychiatry medicines in patients presenting with symptoms of sexual dysfunction.Methods: Medical records of adult patients consulting in the clinic out patients with symptoms of sexual dysfunction were screened for prescriptions of neuropsychiatry medicines. Common neuropsychiatric co-morbidities and prevalence of usage of medicines used for treating neuro-psychiatric disorders was calculated.Results: A total of 628 patients with sexual disorders were included of which 57 (9.1%) had received at least one neuro-psychiatry medicine at the time of presentation. Three most common sexual problems were unconsummated marriage 16 (28.1%), psychogenic ED 14 (24.6%) and organic erectile dysfunction 8 (14.0%). A total of erectile dysfunction 46 (7.3%) patients had psychiatric comorbidity. Five most common neuropsychiatric co-morbidities were anxiety 14 (30.4%), schizhophrenia 10 (21.7%), stress 7 (15.2%), depression 6 (13.0%) and epilepsy 2 (4.3%). The most commonly used neuro-psychiatry medicines were fluoxetine 15 (19.7%), risperidone 11 (14.5%), clonazepam 10 (13.2%), escitalopram 9 (11.8%), alprazolam 5 (6.6%), olanzapine 5 (6.6%) and gabapentin 4 (5.3%). Amisulpride was used in 3 (3.9%) patients whereas valproate, fluoxamine, diazepam and paroxetine were used in 2 (2.6%) patients each. Phenytoin, imipramine, carbamazepine, venlafaxine, haloperidol and sertarline were used in one patient each.Conclusions: Anxiety, schizophrenia and depression are the most common neuropsychiatric disorders in patients with sexual dysfunction. Many patients presenting with sexual dysfunction are already on neuropsychiatry medicines. Further studies are required to evaluate the association between neuropsychiatry medicines and sexual dysfunction in Indian patients.  

Integrative Treatment of Male Sexual Dysfunction (DRAFT)

2018 ◽  
Author(s):  
Jeffrey A. Albaugh
Keyword(s):  
Erectile Dysfunction ◽  
Patient Education ◽  
Sexual Dysfunction ◽  
Premature Ejaculation ◽  
Treatment Options ◽  
Medical Treatments ◽  
Health Goals ◽  
Medicinal Treatment ◽  
Male Sexual Dysfunction ◽  
Pros And Cons

Male sexual dysfunction is common and may include hypoactive sexual desire disorders/lack of libido, premature ejaculation, decreased ability to climax or orgasm, erectile dysfunction, and/or Peyronie’s disease. There are a myriad of cognitive behavioral, integrative, and traditional medicinal treatment options available. Each treatment has pros and cons. Patient education prior to deciding on a treatment is key. Individual patients need to understand the good and bad of each treatment to make an informed decision about how they want to meet their sexual health goals. Traditional medical treatments were discussed in Chapter 4. The aim of this chapter is to describe other nonmedicinal, nonsurgical treatment options for male sexual dysfunction.

Male Sexual Function and Dysfunction (DRAFT)

2018 ◽  
Author(s):  
Jeffrey A. Albaugh
Keyword(s):  
Erectile Dysfunction ◽  
Sexual Dysfunction ◽  
Sexual Function ◽  
Premature Ejaculation ◽  
Lifestyle Modification ◽  
Treatment Options ◽  
Hypoactive Sexual Desire Disorder ◽  
Delayed Ejaculation ◽  
Male Sexual Function ◽  
Desire Disorder

Sexual dysfunction is a common and frustrating problem in men that is often under reported and under treated. Sexual dysfunction issues identified by men may include hypoactive sexual desire disorder/lack of libido, premature ejaculation, delayed ejaculation, erectile dysfunction and/or Peyronie’s disease. This chapter covers information on how normal sexual function occurs and some of the etiologic factors leading to sexual dysfunction. Understanding each individual patient and their goals for sexual health can lead to identifying and addressing sexual issues effectively. Information is provided about some of the traditional medical treatment options typically used to treat men with common sexual problems. In addition, some lifestyle modification and psychological approaches to treating sexual dysfunction are discussed.

Sign in / Sign up

Export Citation Format

Share Document